BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)

    PMA: P990044 · Supplement: S012 · Decision Mar 9, 2012
    View on FDA
    Classifications
    1
    FEI Numbers
    27
    Registration Numbers
    27

    Basic Information

    Device Name
    Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
    Trade Name
    ETI-CORE-IGMK PLUS ASSAY
    PMA Number
    P990044
    Supplement Number
    S012
    Device Class
    FDA Class 3
    Product Code
    LOM
    Generic Name
    Test, hepatitis b (b core, be antigen, be antibody, b core igm)
    Medical Specialty
    Unknown
    Advisory Committee
    Microbiology
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    March 9, 2012
    Date Received
    February 17, 2012
    Supplement Type
    30-Day Notice
    Expedited Review
    N

    Advisory Committee Statement

    CHANGE IN THE QC TEST METHOD USING COMMERCIALLY AVAILABLE ASSAYS FOR THE DETERMINATION OF ANTIBODY ISOTYPE IN RAW MATERIALS, AND THE CHANGE TO ADD MORE STRINGENT ACCEPTANCE CRITERIA FOR SUPPLIER PURCHASED MATERIALS COMMON TO ALL DEVICES.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    LOM Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)